According to the company, information on best worming strategies for foals and yearlings remains largely anecdotal, making it difficult to develop a clear plan for this age group. Zoetis veterinary surgeon Wendy Talbot has therefore reviewed the recent literature to develop an eight-point plan.
Explaining the guidance, Wendy writes:
Foals and yearlings are usually more susceptible to worms than are adult horses because they have had little chance to develop any immunity. They are more vulnerable to related diseases and tend to have higher egg shedding, which increases the risk of infection. The main parasitic culprits in the UK for foals less than six months of age are large roundworms (ascarids). In older foals and weanlings, small and large strongyles, tapeworms (and pinworms) are the main considerations.1 Yearlings may also have a second wave of large roundworm infection at 8-10 months of age.2 Any control strategy will need to take into account the individual circumstances such as stocking density, pasture management and previous disease history.
Guidelines for parasite control in foals suggest a first treatment with fenbendazole at 2-3 months of age, targeting large roundworm, followed by another treatment at 5-6 months. Alternatively, pyrantel may be considered for these doses; however, there may be resistance in some areas and foals with large adult ascarid burdens may be at higher risk of intestinal rupture when this drug is used.4 At weaning (approximately six months of age), it is advisable to perform a faecal worm egg count (FWEC) to determine if treatment for strongyles is also required; the macrocyclic lactone anthelmintics (ivermectin or moxidectin) are expected to have the highest efficacy. At 9 and 12 months of age treatment for stronglyes and a larvicidal dose for encysted stages of small strongyles (moxidectin or a 5 day course of fenbendazole) are indicated. A tapeworm treatment should be included with one of these doses.2,3
For yearlings, two methods have recently been proposed for worm control: the first involves using faecal worm egg counts (FWECs) at more frequent intervals than for adults to guide dosing for strongyles in the grazing season.1 The second suggests three baseline treatments targeting strongyles in spring, summer and late autumn, with FWECs in between to identify and treat any still shedding high numbers of eggs, up to a maximum of six treatments per year.2 Macrocyclic lactones have the highest expected efficacy against small strongyles and should form the basis of treatments; however, pyrantel can be considered for some treatments where it has been shown to have continued efficacy. Both strategies include a larvcidal treatment for encysted small redworm combined with testing or treating for tapeworm in late autumn. The inclusion of one or two doses of a macrocyclic lactone each year (usually already used for small strongyle control) should be sufficient to prevent large strongyle related disease.3
The wide differences in the circumstances of foals and yearlings, together with geographical variations in resistance patterns and a lack of consensus on best practice in this group means it is not possible to define a single approach to a worming plan. An important point to note is that FWECs may give surprising results because higher counts are generally seen in youngstock.
Eight ways to keep clients' youngstock worms controlled:
For further information on worming together with some equine specific CPD visit: https://blog.vetsupportplus.com/
The new GPCert programme, led by course director Owen Davies MA VetMB MVetMed MANZCVS (Small Animal Medicine) DipACVIM (Oncology) (pictured right), consists of 12 modules covering key clinical subjects in veterinary oncology delivered over 14 months.
Each module consists of nine lessons, two case studies, course notes and weekly summary videos.
Lessons are supported by notes and videos, quizzes and a forum tutored by leading specialists.
Owen said: “Half of all canine cancers are treatable if caught early enough and new treatments are continuously being researched.
"The programme will guide delegates through the latest knowledge in state-of-the-art, compassionate cancer care for animals, helping them to provide safe and comprehensive diagnostics and treatments.”
For more information, visit: https://www.improveinternational.com/uk/course/oncology-online-learning/
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
A new expert panel has been formed to evaluate pain management in canine osteoarthritis following a recent shift to a more integrated approach to pain and disease research.
In the past, pain and joint disease have been considered as separate areas of research, with pain perceived simply as a consequence of disease. Over the last few years, however, it has become increasingly apparent that the relationship is far more complex and that pain may be a driver of disease rather than just a consequence of it. The expert panel hopes to apply the new knowledge to the management of joint pain in veterinary practice.
The panel, which had its inaugural meeting in Paris recently, brings together acknowledged veterinary experts in the fields of pain and joint disease. Its focus will be on the assessment and management of pain in canine osteoarthritis (OA), with the objective of educating veterinary surgeons to better understand and manage pain in canine OA and thereby improve the well-being of pets that suffer from this common disease.
'Central sensitisation' is one of the latest theories that has been suggested to explain the complex interaction between pain and disease progression in canine OA. Duncan Lascelles, Associate Professor of Surgery at North Carolina State University, said that research has shown that the components of the pain pathway can change in response to a pain stimulus. Pain receptors 'up-regulate' in response to painful stimuli and become more sensitive to subsequent pain.
CNS sensitisation is likely a significant contributor to chronic or maladaptive pain; this pain leads to decreased mobility, reduced muscle support and reduced muscle function, thus leading to disease progression. In other words, joint diseases cause pain, which in turn feeds back to create more disease.
Professor Lascelles said: "The link between the clinical signs associated with OA and joint pathology is not a simple one and may be much more complex than we have previously thought.
"There is some evidence that COX inhibition reduces central sensitisation. And some evidence suggests that reducing central sensitisation may have a modulatory effect on disease progression by reducing signals going out to the periphery.
"The relationship between pain and disease progression is a very new area of research, and is at the forefront of our knowledge of how pain and joint disease are linked."
Professor John Innes, Head of Division, Small Animal Studies, University of Liverpool Veterinary School, told the meeting that OA is likely to be one of the major reasons for euthanasia of pet dogs in Europe. He and two co-investigators have performed a systematic review of the published evidence for the use of long-term, continuous NSAID treatment (at least 28 days) in OA. They found that this form of management is associated with better outcomes than short-term NSAID therapy, with no evidence of additional safety issues. This review is to be published shortly.
The expert panel comprises:
Prof Dr Stuart Carmichael, Vets Now Ltd. Formerly at: Veterinary School, University of Glasgow, UKProf Dr John Innes, Small Animal Teaching Hospital, University of Liverpool, UKDr Bernard Bouvy-Centre, Hospitalier Vétérinaire de Frégis, Arcueil, FranceProf Dr Jean-Pierre Genevois, Ecole Nationale Vétérinaire de Lyon, FranceDr Carlos Macías, Centro Veterinario de Referencia Bahia de Malaga, SpainProf Dr Martin Kramer, Klinik für Kleintiere, Chirurgie , Justus-Liebig-Universität Gießen, GermanyDr Sabine Tacke, Klinik für Kleintiere, Chirurgie, Justus-Liebig-Universität GießenProf Dr Duncan Lascelles, North Carolina State University College of Veterinary Medicine, Raleigh, USAProf Dr Herman A.W. Hazewinkel, Faculteit Diergeneeskunde, Departement Gezelschapsdieren, Utrecht, NetherlandsDr Emilio Feltri, Anaesthetist and specialist in Pain Management, Ambulatorio Veterinario Associato, Tortona, ItalyDr Peter Vandekerckhove, Specialist Surgeon Companion Animal, Wondelgem, Belgium
45% of British pet owners believe their four legged friends share their human emotions and can sense when they are upset or unwell, according to a new survey announced by Bayer Animal Health.
The 'Pets are Human Too' study of 3,000 British dog and cat owners was commissioned by the company to celebrate Drontal's www.mypetsuperstar.com competition.
According to the study:
TV vet and My Pet Superstar Judge Emma Milne, said: "The joy and companionship our pets bring to our lives is unquestionable and it is no wonder that many consider them to be 'man's best friend'. Britain is a nation of proud pet owners and now, with the launch of My Pet Superstar, we all have a chance to show them off!"
The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).
In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.
However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.
The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.
The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.
Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.
"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.
"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.
"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."
Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.
"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."
Nominations are now open for candidates wishing to stand in the 2012 RCVS Council and RCVS Veterinary Nurses Council elections.
Jane Hern, RCVS Registrar said: "The veterinary surgeons and veterinary nurses that sit on the RCVS and VN Councils are vital to the governance of their professions, and in steering the activities the College undertakes under its Royal Charter. If you're interested in making sure that your profession is well-governed, its standards are upheld, and the interests of animals and the public are protected, why not consider standing in these elections?"
Six seats on RCVS Council and two on VN Council are due to be filled in the 2012 elections. Those elected will take their seats on RCVS Day next July, to serve four-year terms, and will be expected to spend at least six to eight days a year attending Council meetings, working parties and subcommittees (a loss-of-earnings allowance is available).
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, manifesto and photograph for inclusion in the RCVS News Extra election specials. Nobody may nominate more than one candidate, and no current member of the RCVS Council or VN Council may make a nomination.
Nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2012. Full details and guidance notes for both elections will be available on the RCVS website shortly on the RCVS Council Election page and VN Council Election page.
Nomination forms and candidate information forms for RCVS Council may be requested from Mrs Gabi Braun (020 7222 0761 or executiveoffice@rcvs.org.uk) and those for VN Council from Mrs Annette Amato (020 7202 0713 or a.amato@rcvs.org.uk).
The hands-on course, which is worth 7 CPD hours, has been organised by Dr Nicola M Parry, Recognised Specialist in Pathology at the University of Surrey School of Veterinary Medicine. It will combine lectures, practicals, and a Q&A session to enable delegates to carry out a post-mortem, identify common (and not so common) pathologies, and draw conclusions about the cause of death.
The morning lectures will provide an overview of techniques that focus on how to approach the post-mortem examination of the adult horse and the foetus/foal, as well as how to examine the placenta. Potential findings will be discussed as well as some pitfalls to avoid during the post-mortem examination, and how to optimise sample submission. The lectures will be recorded, enabling sessions to be reviewed later.
Delegates will spend the afternoon in the post-mortem room, examining macroscopic specimens and learning practical approaches to a post-mortem examination in the field, and the collection of key specimens. The day will close with a Q&A session.
Speakers Dr Fabio Del Piero from the Louisiana State University and Dr Marvin J Firth from the University of Surrey will help delegates to:
Sarah Gaspar, the Learning Manager at BEVA said: “If you have ever been called out to a dead horse to find a distraught owner and not been sure how to identify the cause, this course is for you. We can’t remember any course ever having been run on this topic in the UK before; it is likely to be very popular so be quick to book.”
To find out more and to book click here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1582
Woodley Equipment Company has become the exclusive Europe-wide distributor for the new Epoc Hand Held Clinical Care Analyser from Epocal Inc
Woodley says the Epoc, developed by the founder of the i-STAT analyser, is the first wireless point of care testing solution to use smart card technology. The Epoc provides immediate blood gas, electrolyte and critical care biochemistry results directly to a hand held PDA (included) and wirelessly interfaces with your in-practice computer. It is a completely affordable analyser that is easy to use and requires no refrigeration of consumables.
Key Features:
For a more information about the Epoc Blood Gas Analyser please email sales@woodleyequipment.com, visit woodleyequipment.com, or call Woodley's customer service team on +44 (0)1204 669033 ~ Option 1
The RCVS has announced the results of the RCVS Council and VN Council elections.
Re-elected to three of the six seats available on RCVS Council were current President Neil Smith (1,687 votes), incoming Standards Committee Chairman David Catlow (1,656) and Vice-President Jacqui Molyneux (1,304); and, from RCVS Day on 11 July 2014, they will be joined by new members David Bartram (1,674), Susan Paterson (1,496) and Mandisa Greene (1,296).
The two available places on VN Council were taken by existing member Hilary Orpet (611 votes) and new member Amber Richards (371).
Notably, half of the successful RCVS Council candidates this year were women, two of whom being elected for the first time.
Overall turnouts in both elections fell, with 4,137 (16.1%) veterinary surgeons and 1,157 (10%) veterinary nurses voting. These turnouts and voter numbers compare with 4,661 (18.8%) and 1,329 (12.5%) last year, and ten-year averages of 3,927 (17.4%) and 869 (9.9%), respectively.
RCVS Registrar Gordon Hockey, said: "It was always going to be tough to beat last year's record turnout, even with a record number of candidates standing this year, but it's encouraging that voter numbers are still the third highest in the last ten years.
"I'd like to be amongst the first to publicly congratulate all the successful candidates this year, and to encourage those who weren't successful this time to stand again in the future. I'm very much looking forward to working with our three new RCVS Council members whilst, at the same time, delighted that the profession has returned three existing members to their seats, enabling them to continue their work for the College."
Chair of VN Council, Kathy Kissick, says: "Many congratulations to Hilary, who has been returned to the VN Council for the third time running, and to Amber, who I'm looking forward to welcoming to VN Council in July. Hilary's experience and Amber's fresh input will, I'm sure, combine to provide an excellent contribution to our ongoing work."
Wiley has announced the joint online publication of a special issue of 22 ophthalmology papers from Equine Veterinary Journal, Equine Veterinary Education and Veterinary Ophthalmology.
Clinical equine ophthalmology: The current state of the art brings together papers on some of the most significant advances in equine clinical ophthalmology into a single issue to make them more readily available to a wider audience. The issue contains information of direct relevance to all sectors of the veterinary profession from general practitioners and specialists to researchers, surgeons and students, covering common diseases, surgical procedures and outcomes.
The new publication was devised and compiled by a panel of guest editors comprising Mary Lassaline, member of the Veterinary Ophthalmology Editorial board and Veterinary Ophthalmologist in the Department of Surgical and Radiological Sciences at UC-Davis School of Veterinary Medicine, California, David A. Wilkie, Editor of Veterinary Ophthalmology and Professor at Veterinary Clinical Sciences Comparative Ophthalmology Ohio State University, Tim Mair, Editor of Equine Veterinary Education based at Bell Equine Veterinary Clinic, Kent and Celia M Marr, Editor of Equine Veterinary Journal, based at Rossdales, Newmarket.Mary Lassaline said: "The goal was to provide broad access to the most current information applicable to every stratum of the equine veterinary profession. Subsequently, a salient feature is that many of the papers included are collaborations between veterinary ophthalmologists with a special interest in horses, equine practitioners with a special interest in ophthalmology, private practitioners and those in academia, and academicians from different institutions."
Subjects covered include seven papers on new approaches to the diagnosis and treatment of ulcerative and non-ulcerative keratitis in the horse. There are three articles on novel approaches to corneal surgery and a further three on corneal neoplasia. Six papers provide valuable data regarding long-term outcomes following surgical intervention for Equine Recurrent Uveitis (ERU), glaucoma, and cataracts. Finally, three articles present new information regarding retinal and orbital disease.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "The key purpose of the EVJ is to disseminate information to help the enhancement of specialist knowledge at every level of the veterinary profession. By collating the most important and up-to-date ophthalmology research into one easy resource the new special issue does exactly that."The ophthalmology special issue is available free online at: http://bit.ly/1bi0RG0
The Association says it delayed this decision as late as possible, and whilst the most recent government advice does not prohibit large public gatherings, it recognises the importance of personal safety for Congress attendees and the need to support the profession in preserving business continuity, maintaining client services and protecting animal welfare.
Amanda Stranack, BSAVA CEO, said: "As the situation continues to escalate, the government have given a clear steer that they expect more stringent controls to come into force in the coming weeks. With Congress now only a few weeks away, we want to give all our attendees as much notice as possible, both to ensure peace of mind, and to give people adequate time and flexibility to change their plans.
"BSAVA recognises the pressures the current situation brings to bear on the veterinary community and in making this difficult decision, has the interests of the profession first and foremost in its mind.
"We would thank all those who have worked hard over the past two years to contribute to the development of Congress, a huge amount of effort goes into preparations from BSAVA volunteers, Congress participants and our staff."
Sue Paterson, BSAVA President, said: "It is with great regret that we have made the difficult decision to cancel Congress, which has taken place annually for more than 60 years. Congress is an incredibly important event in the veterinary calendar, and we were all looking forward to an inspiring agenda and saying a fond farewell to the city that has made Congress such a great success over so many years. The health and wellbeing of our attendees is of utmost importance to us, and whilst we are sorry to be making this decision, we are confident it is the right one."
BSAVA says it is aware of the impact that cancelling will have on many delegates' CPD hours, so it is now looking at other ways it can deliver Congress lectures and podcasts.
Sue added: "Whilst we won’t be able to deliver the full Congress programme, we will be working with our speakers to capture as many lectures as we can to make content available online."
The centre, which is one of the largest animal hospitals in the UK, offers 14 specialist-led services.
Hospital director Daniel Hogan said: “The new hospital will provide the region with one of the largest and best-equipped veterinary centres in not only the UK, but also throughout Europe, with an extensive range of expertise in a wide variety of disciplines all under one roof.
“There will be seven operating theatres, 16 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and there are plans for a future hydrotherapy suite.
“The facilities also include a cutting-edge imaging suite, comprehensive treatment facilities and a new linear accelerator to assist our illustrious oncology team.
"We also plan to launch our emergency and critical care service in the first half of 2023.”
Southfields says it also aims to lead the industry in terms of staff wellbeing and sustainability.
Daniel said: “The increased size of the hospital will enable us to provide a dedicated staff wellbeing area and offer a range of activities which will benefit our team in both body and mind.
“Along with exercise and relaxation classes such as yoga and boxercise, we will have an education centre which will be able to offer some really exciting qualifications and courses for the wider profession.
“We’ll also be striving to care for both our community by working with Investors in the Environment (iiE) to introduce a bold green initiative to substantially reduce our environmental impact and enhance our sustainability.
https://southfields.co.uk/veterinary-professionals/new-hospital
The results of a new study1 highlighting the prevalence of Angiostrongylus vasorum infection as seen by UK veterinary surgeons, combined with the low awareness amongst dog owners of this parasite2 has led Bayer Animal Health to launch a nationwide 'Be Lungworm Aware' initiative.
Backed by a hard-hitting national advertising, PR and radio campaign which kicks off in April, the initiative aims to highlight the prevalence of this potentially, and often fatal infection, and to drive pet owners to their veterinary practices for further information.
The initiative also sees the launch of a new educational website for dog owners - http://www.lungworm.co.uk/. The site offers further information on the infection, including likely signs, how to obtain treatment and a video of the lifecycle of the parasite showing the threat posed by the lungworm's intermediate hosts - slugs and snails.
The study revealed that 16% of vets questioned had one or more confirmed cases of the disease. A further 10% had seen dogs that they suspected had the infection. However, only 6% of dog owners questioned in a UK wide survey had unprompted awareness of the parasite.
Bayer's Chris White said: "These results are no surprise following the reports last year of confirmed cases of Angiostrongylus vasorum as far north as Glasgow. The disease has seen a rapid rise in importance over the past few years highlighted by the number of vets and nurses that attended the Advocate CPD meetings held around the country at the end of last year.
"The 'Be Lungworm Aware' initiative aims to educate owners on the risks associated with infection, to encourage them to visit their vet for further information and discuss their dogs' parasite protection plan."
For further details, or to order the supporting practice materials, including a new educational waiting room display and practice PR pack to help raise awareness locally, please contact your Bayer representative or ring 01635 563682.
1Insight Track, 2008 2Insight Track, 2009
For practices planning to take part in National Microchipping Month, Virbac is providing a personalised poster design service and chip promotion throughout June.
According to product manager Gillian Brown, the idea is to offer additional tailored support to practices during the promotional period: "Obviously many practices will have National Microchipping Month materials in place, but the price each practice offers their clients is individual to them. These posters provide a visual platform to highlight the promotion.
"To take advantage of the scheme, practices just need to notify their territory manager of the price they propose to charge and we will then manage the design and print."
Virbac will also be offering a promotional chip price in June to support National Microchipping Month. Gillian said: "Microchipping is now the official means of pet identification approved by the EU Pet Passport Scheme. This will help practices provide an attractive promotion to pet owners and hopefully encourage greater up-take of microchipping."
Any practice interested in the initiative should contact their local Virbac territory manager or call Virbac on 01379 243243.
CM Research has announced the results of a survey conducted this month in which veterinary surgeons named Osurnia as the best new product of 2015.
290 companion animal veterinary surgeons took part in the survey, which is designed to provide veterinary surgeons with their peers’ unbiased judgement on which new veterinary products, services or devices have made the biggest impact on the industry.
The questions were unprompted to ensure that the respondents were not influenced by pre-set survey options. CM Research points to the fact that many of the products that featured in its rankings were launched before 2015, including 2nd and 3rd placed Apoquel and Bravecto, as evidence of this freedom.
The full list of products named more than once in this year's survey was:
Product
Manufacturer
Number of mentions
% of mentions
Osurnia
Elanco
67
23%
Apoquel
Zoetis
58
20%
Bravecto
MSD
29
10%
Semintra
Boehringer Ingelheim (BI)
13
4%
Amodip
Ceva
10
3%
Nexgard Spectra
Merial
8
Broadline
6
2%
UpCard
Vetoquinol
Zodon
5
Metabolic Diet
Hill's
4
1%
Nexgard
SDMA Test
IDEXX
Comfortis
3
Remend
Bayer
Seresto
Yumove
Lintbells
Bovela
BI
2
Comfortan
Dechra
Hill's y/d diet
Nutraquin
Nutravet
Pexion
Prinovox
Virbac
Pronefra
Thiafeline
Animalcare
Veraflox
Vetigel
Suneris
Cardalis
The company points to an increasing trend across Europe towards feeding raw diets to pets, with 4% of UK cats and 10% of UK dogs now being fed raw meat and animal by-products.
The webinar, which will also look at the role of testing, offers an opportunity to learn more about the pathogens and parasites associated with raw feeding and the role of the right test at the right time.
Horiba says it's not just pets that need testing, but the raw materials used in their food.
Ian, who is Head of ESCCAP (the European Scientific Council for Companion Animal Parasites) UK & Ireland, said: “The recent trend of increasing raw feeding opens up new opportunities for pathogen transmission.
"Where raw feeding is taking place, adequate tapeworm and protozoal parasite prevention is essential to reduce zoonotic risk and economic losses.
“Testing forms an essential part of their control, and understanding this role and the diagnostic test options available will prove valuable to all veterinary professionals.”
Following Ian's presentation, there will be an open Q&A session.
Horiba’s team of veterinary specialists will also be available at the end of the webinar to discuss and advise on any testing needs, including its veterinary PCR system, the POCKIT Central.
To register, visit: https://register.gotowebinar.com/register/4306408134214190348
To help veterinary practices engage with pet owners and help them understand the importance of eye health, TVM has produced a range of free educational materials including waiting room displays, informative web pages and social media packs.
The company has also published a page of information at www.tvm-uk.com/eyehealth – where pet owners can find out more about eye problems, how to spot them and learn what can be done about them.
Emma Hancox MRCVS, Veterinary Advisor at TVM said: "It can be easy for owners to miss the signs of problems with their pet’s eyes, but they can be extremely distressing for animals and be a sign of conditions ranging from cataracts and glaucoma through to conjunctivitis - all of which can be painful, and in the worst-case scenario, lead to blindness.
"We hope that National Pet Eye Health Awareness Week will help practices assist owners in understanding the importance of eye health and prevent more serious conditions occurring."
To request your board kit and pet owner leaflets, and download your free social media pack, visit www.tvm-uk.com/eyehealth or contact your Territory Manager.
The device emits low dose 265 nanometre (nm) ultraviolet C light at a targeted area.
In a 2022 in vitro / ex vivo study to evaluate the therapeutic potential of 265nm UVC for infectious keratitis1, UVC was found to inhibit all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance.
In the study, no evidence of infection was found from 4 hours onwards, ulcers responded significantly in under 24 hours, and at the end point, those treated with UVC performed as as well as those treated with ciprofloxacin.
Photon Therapeutics says that in simple cases, one five-second treatment will suffice, but more complex cases can be re-treated after 24 hours.
Currently, there are two main barriers to the successful treatment of eye infections in dogs.
The first is the difficulty diagnosing the infection and identifying the right antimicrobial to use, highlighted by a 2017 study: Bacterial Isolates from Canine External Ocular Disease and their Antimicrobial Sensitivities 2.
The second is whether the owner is able or willing to administer a topical treatment.
Here the evidence suggests that even when treatment is possible, people do not comply with clinical advice anything like as much as they claim.
Photon Therapeutics points to what it says is the nearest study there is, in which carers of young children with uveitis did not give the correct treatment in 75% of cases3.
If the device is as effective as claimed, then both these issues simply evaporate.
PhotonUVC costs £4,995.
https://photon-therapeutics.com
VetSurgeon.org product briefing: https://www.vetsurgeon.org/m/veterinary-product-briefing/138134
References
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
The organisers have invited veterinary experts to share their knowledge and expertise in gastroscopy, sinoscopy and upper respiratory tract (URT) endoscopy, using cadaver heads and state of the art models, during daily practical sessions.
Practical sessions will guide delegates through the most commonly used equine endoscopy procedures, including how to perform gastroscopy, how to perform upper respiratory tract endoscopy and exploration of the guttural pouches and how to get the most out of sinoscopy.
Each session will include a review of the anatomy involved and helpful tips from experts Jonathan Anderson, Tim Barnett, Imogen Comyn, Ollie Crowe, Sarah Mack, Patrick Pollock, Alex Rafferty, Richard Reardon, Neil Townsend, Sophie Wilford and Tom Witte.
The gastroscopy practical will make use of a custom synthetic model of a horse’s oesophagus and stomach, uniquely developed by BEVA, Burtons and DeLegge Medical Design in the USA. The URT endoscopy practical will utilise cadaver heads on stands so delegates can look at laryngeal components, sinus drainage angle, ethmoids, guttural pouch ostia and can then scope/ pass foley catheters/chambers catheters in to guttural pouches. Pre-prepared cadaver heads will also be used for the sinoscopy practicals. Frontal sinus trephine holes will allow a scope to be inserted and one side will be broken through the maxillary septal (ventral conchal) bulla so delegates can compare the differences in anatomy.
At the end of each demonstration Burtons, who have sponsored the event and supplied the endoscopic equipment, will be providing advice on how to clean and maintain scopes properly.
Mark Bowen, President of BEVA, said: "BEVA is committed to providing innovative and practical CPD through its entire CPD programme, including congress and these practical sessions showcase the excellent and varied education provided to members. At a time when the RCVS are considering the value of certain types of CPD in improving professional competence, BEVA is committed to leading the field and challenging perceptions of what a modern conference can be."
The practical sessions will run on all three days of Congress on the balcony above the exhibition hall. Each session will comprise a demonstration and then three practical slots, each for a maximum of ten delegates. Places can be secured on a first come first served basis by signing up on the day.
Visit www.beva.org.uk to find out more and to sign up.
NDSR’s director of neurology Rodolfo Capello said: "This technology is one of the most advanced in medicine and helps to surgically remove tumours while also reducing the tissue damage to vital structures.
"The accuracy and control of the system offers us greater versatility and precision, and minimises invasive manoeuvres during both soft and hard tissue dissections.
"Surgeons can therefore be extremely confident of accurate tumour excision with reduced blood vessel and tissue damage which will all help increase and improve the outcome of our surgeries.
"We’ll be using the ultrasonic surgical aspirator for the removal of tumours in the brain, liver and to cut through bone where necessary. It will be a great asset."
For more information, visit: www.ndsr.co.uk
Happy Snack is described as a light, delicious creamy snack which contains alpha-casozepine, a natural milk protein with claimed appeasing properties.
In a study conducted by the company, the new treat was taken by 86% of cats.
Happy Snack is suitable for cats and kittens from 12 weeks of age and can be used directly from the sachet, on food or from a finger.
Feline behaviourist, Lucy Hoile, said: “I am very excited about Happy Snack, as I think there is a real gap in the market!
"Something delicious that a person can give easily to a cat, is a great tool to help with general distraction and bond building.”
Happy Snack by Feliway is available in packs of six sachets.
www.feliway.com/uk.
Dunfermline-based Vets Now Ltd has been announced as the winner of the Scotland regional final of the £35 Million Bank of Scotland Corporate Entrepreneur Challenge. The company, based on Pitreavie Drive, is the UK's leading provider of out of hours emergency care for animals and has secured an incredible funding package of up to £5 million, free of interest and charges for three years, to turn their expansion plans into reality.Richard Dixon, Managing Director of Vets Now Ltd, said, "I am absolutely thrilled that we have won the Scottish regional final of the Entrepreneur Challenge. A lot of time and effort went into our presentation and we knew that the competition was going to be tough. I'm very proud of our team, without who Vets Now would not be what it is today."Winning the Challenge is going to have a fundamental impact on Vets Now, taking our business to a completely new level. The funding will allow us to make substantial growth and move the business into Europe. It will also increase the range of services we can provide to customers and increase the overall profile of our organisation."Richard will now go through to the national final in December, where he will compete against the winners from six other regions across the UK for the chance to be named ‘Entrepreneur of the Year' and the opportunity to benefit from four days mentoring from one of Britain's most successful and high profile entrepreneurs.Vets Now was chosen as the winner after Richard Dixon presented his business case and plans for the future to a panel of judges, including Willie Haughey from City Refrigeration and John Anderson from The Entrepreneurial Exchange. Willie, John and the rest of the judging panel then questioned Richard in their search for an entrepreneur who displayed flair, vision and creativity, coupled with solid business acumen and impressive plans for the future. The judging was followed by a dinner and award ceremony at Stirling Castle, at which the winner was announced.For more information visit http://www.theboschallenge.co.uk/
Dechra Veterinary Products has produced a pair of presentations, aimed at pet owners, for vets to use in receptions and at client events. The presentations cover canine hyperadrenocorticism, aka Cushing's syndrome, and feline hyperthyroidism.
Matthew Olsen, Product Manager, said: "We are committed to delivering a wide range of support materials and tools to enable vets to provide help and information to their customers. We have developed an owners' booklet on both Cushing's and hyperthyroidism and have now backed this up with PowerPoint presentations for vets to use with their clients. Some veterinary practices are using technology to revolutionise waiting room displays and we have responded to their needs by producing a presentation they can use on their waiting room information screens."
The Dechra Hyperadrenocorticism presentation covers what Cushing's is, what causes it and what owners need to look for. The presentation also explains the treatment options available. The Hyperthyroidism presentation details what the condition is and gives information on the thyroid gland. It highlights what cat owners need to look out for, including weight loss in spite of a ravenous appetite, increased fluid intake and increased restlessness. The presentation also advises people of what to do should they suspect their cat has hyperthyroidism and what the treatment options are.
Garden Lodge Veterinary Clinic in Holywood, County Down, has used the Hyperthyroidism presentation at both its practices. Partner Tom Fitzsimons said: "We have used the presentation on our reception information screens. The presentation has raised owners' awareness and shown them it is a manageable condition. It's led to an increase in the number of cats we are now testing for Hyperthyrodism. We also plan to run the Cushing's presentation in the future."
Veterinary Practices interested in getting hold of a free copy of the Hyperthyrodism and Hyperadrenocorticism presentations should contact Matthew Olsen at Dechra on 01743 441 632 or email matthew.olsen@dechra.com